MiMedx Group, Inc. (MDXG)

MiMedx Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	58.23	-30.2	-10.29	-83.33	-25.58
Depreciation & Amortization	4.7	5.31	6.17	7.84	8.53
Share-Based Compensation	16.96	11.33	14.16	15.36	12.06
Other Operating Activities	-53.11	-4.33	-12.03	29.87	-34.43
Operating Cash Flow	26.78	-17.89	-1.98	-30.26	-39.41
Capital Expenditures	-1.99	-1.49	-3.22	-4.23	-1.75
Acquisitions	0	-1	0	0	0
Change in Investments	0	0	0.08	0	2.72
Other Investing Activities	-0.17	-0.17	-0.25	-0.33	-0.47
Investing Cash Flow	-2.16	-2.66	-3.4	-4.56	0.5
Share Issuance / Repurchase	1	-0.54	-3.31	-9.39	-1.37
Debt Issued / Paid	-0.05	-0.04	-0.04	-25.81	70.88
Other Financing Activities	-9.52	-	-	96.77	-6.65
Financing Cash Flow	-8.57	-0.58	-3.35	61.56	62.86
Net Cash Flow	16.05	-21.13	-8.73	26.74	23.95
Free Cash Flow	24.79	-19.38	-5.2	-34.49	-41.16
Free Cash Flow Margin	7.71%	-7.24%	-2.15%	-13.89%	-13.76%
Free Cash Flow Per Share	0.21	-0.17	-0.05	-0.32	-0.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).